LogicBio Therapeutics, Inc. Contracts & Agreements

Amended and Restated Exclusive Research Collaboration, License and Option Agreement, dated as of October 2, 2022, between LogicBio Therapeutics, Inc. and CANbridge Care Pharma... (Filed With SEC on November 14, 2022)

Agreement and Plan of Merger, dated as of October 3, 2022, by and among LogicBio Therapeutics, Inc., Alexion Pharmaceuticals, Inc. and Camelot Merger Sub, Inc (Filed With SEC on October 3, 2022)

Consulting Agreement by and between Cecilia Jones and LogicBio Therapeutics, Inc., effective as of September 23, 2022 (Filed With SEC on September 23, 2022)

Amendment No. 8 to Amended and Restated (Equity) Agreement, dated as of May 27, 2022, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics, Inc (Filed With SEC on August 15, 2022)

Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Daniel Gruskin, dated August 5, 2020 (Filed With SEC on May 16, 2022)

Form of At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement applicable to Daniel Gruskin (Filed With SEC on May 16, 2022)

Amendment No. 7 to Amended and Restated (Equity) Agreement, dated as of December 7, 2021, between The Board of Trustees of the Leland Stanford University and LogicBio... (Filed With SEC on March 4, 2022)

Form of Indemnification Agreement applicable to directors and executive officers (Filed With SEC on November 15, 2021)

Form of Inducement Award Agreement (Filed With SEC on November 15, 2021)

Amendment No. 6 to Amended and Restated (Equity) Agreement, dated as of March 29, 2021, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics,... (Filed With SEC on May 10, 2021)

Third Amendment to Loan and Security Agreement, dated March 31, 2021, by and between the Company, LogicBio Australia Pty Limited, Oxford Finance LLC and Horizon Credit II LLC (Filed With SEC on May 10, 2021)

Amendment No. 5 to Amended and Restated (Equity) Agreement, dated as of October 30, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio... (Filed With SEC on March 15, 2021)

Form of Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Cecilia Jones (Filed With SEC on March 15, 2021)

First Amendment to Loan and Security Agreement, dated April 23, 2020, by and between the Company, LogicBio Australia Pty Limited, Oxford Finance LLC and Horizon Credit II LLC (Filed With SEC on November 9, 2020)

Second Amendment to Loan and Security Agreement, dated September 28, 2020, by and between the Company, LogicBio Australia Pty Limited, Oxford Finance LLC and Horizon Credit II LLC (Filed With SEC on November 9, 2020)

Amendment No.2 to Patent & Technology License Agreement, dated September 29, 2020, by and between LogicBio Therapeutics, Inc. and The Board of Regents of The University of Texas... (Filed With SEC on November 9, 2020)

Underwriting Agreement, dated October 1, 2020, among LogicBio Therapeutics, Inc. and Jefferies LLC, Barclays Capital Inc., and William Blair & Company, L.L.C., as representatives... (Filed With SEC on October 5, 2020)

Amendment No 4 to Amendment and Restated (Equity) Agreement, dated as of April 29, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics,... (Filed With SEC on August 10, 2020)

Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Kenneth Huttner (Filed With SEC on May 11, 2020)

Description of the Registrants Securities (Filed With SEC on March 16, 2020)

Amendment No. 1 to Amended and Restated (Equity) Agreement, dated as of May 3, 2018, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics, Inc (Filed With SEC on March 16, 2020)

Amendment No. 3 to Amended and Restated (Equity) Agreement, dated as of January 29, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio... (Filed With SEC on March 16, 2020)

Amendment No. 1 to Patent & Technology License Agreement, dated October 14, 2019, by and between LogicBio Therapeutics, Inc. and The Board of Regents of Thu University of Texas... (Filed With SEC on March 16, 2020)

Form of Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Seokho Bryan Yoon (Filed With SEC on March 16, 2020)

Lease Agreement dated as of November 4, 2019, between LogicBio Therapeutics, Inc. and HCP/King Hayden Campus LLC (Filed With SEC on March 16, 2020)

Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Dean Falb (Filed With SEC on November 12, 2019)

Amendment No. 2 to the Amended and Restated Exclusive (Equity) Agreement, dated as of June 24, 2019, between the Company and The Board of Trustees of the Leland Stanford University (Filed With SEC on August 13, 2019)

Form of Warrant to Purchase Common Stock of LogicBio Therapeutics, Inc., dated as of July 2, 2019 (Filed With SEC on July 2, 2019)

Loan and Security Agreement dated as of July 2, 2019, among Oxford Finance LLC, the Lenders listed on Schedule 1.1 thereto and Horizon Technology Finance Corporation and LogicBio... (Filed With SEC on July 2, 2019)

Patent License Agreement dated December 14, 2018, between the U.S. Department of Health and Human Services, as represented by the National Human Genome Research Institute, an... (Filed With SEC on April 1, 2019)

Form of Underwriting Agreement (Filed With SEC on October 9, 2018)

Form of Specimen Common Stock Certificate (Filed With SEC on October 9, 2018)

Amended and Restated Exclusive (Equity) Agreement dated January 31, 2018, between The Board of Trustees of the Leland Stanford Junior University and LogicBio Therapeutics, Inc (Filed With SEC on October 9, 2018)

Patent & Technology License Agreement, dated May 7, 2018, by and between LogicBio Therapeutics, Inc. and The Board of Regents of the University of Texas System (Filed With SEC on October 9, 2018)

Form of Indemnification Agreement (Filed With SEC on October 9, 2018)

Form of Stock Option Agreement under the LogicBio Therapeutics, Inc. 2014 Equity Incentive Plan (Filed With SEC on October 9, 2018)

Form of Restricted Stock Agreement under the LogicBio Therapeutics, Inc. 2014 Equity Incentive Plan (Filed With SEC on October 9, 2018)

LogicBio Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 9, 2018)

LogicBio Therapeutics, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on October 9, 2018)

LogicBio Therapeutics, Inc. 2018 Cash Incentive Plan (Filed With SEC on October 9, 2018)

Form of Incentive Stock Option Agreement under the LogicBio Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 9, 2018)

Form of Non-Statutory Stock Option Agreement under the LogicBio Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 9, 2018)

Form of Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Frederic Chereau (Filed With SEC on October 9, 2018)

Form of Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Matthias Jaff (Filed With SEC on October 9, 2018)

Form of Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Tom Wilton (Filed With SEC on October 9, 2018)

Investors Rights Agreement, dated as of June 19, 2017, by and among LogicBio Therapeutics, Inc. and each of the Investors and Common Holders listed therein (Filed With SEC on September 25, 2018)

Amended and Restated Exclusive (Equity) Agreement dated January 31, 2018, between The Board of Trustees of the Leland Stanford Junior University and LogicBio Therapeutics, Inc (Filed With SEC on September 25, 2018)

Patent & Technology License Agreement, dated May 7, 2018, by and between LogicBio Therapeutics, Inc. and The Board of Regents of the University of Texas System (Filed With SEC on September 25, 2018)

LogicBio Therapeutics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on September 25, 2018)

Consulting Agreement with Mark Kay, dated April 1, 2018 (Filed With SEC on September 25, 2018)

Category

Industry

Companies

Contracts

LogicBio Therapeutics, Inc. Contracts & Agreements